Kisunla (Donanemab) (Donanemab) — Uses, Dosage, Side Effects & Safety

Drug class: Monoclonal Antibody; Anti-amyloid Agent

Overview

Kisunla (Donanemab) is a prescription medication used to treat early symptomatic Alzheimer's disease, including mild cognitive impairment and mild dementia due to Alzheimer's. It is designed to slow the progression of cognitive and functional decline in adults diagnosed with this condition. Kisunla works by targeting and removing amyloid beta plaques in the brain, which are believed to contribute to the development and progression of Alzheimer's disease. By reducing these plaques, Kisunla may help preserve memory and thinking abilities for a longer period. Key points for patients: Kisunla is given as an intravenous infusion, usually once every four weeks. It is not a cure for Alzheimer's disease, but it may help slow down symptoms. Regular monitoring and follow-up with your healthcare provider are important to ensure safety and effectiveness.

Therapeutic uses

  • Alzheimer's disease

For related Kisunla (Donanemab) guidance, compare A Comprehensive Guide to Alzheimer's Disease and Dementia.

Common side effects

  • Amyloid-Related Imaging Abnormalities (ARIA)
  • Headache
  • Nausea
  • Vomiting
  • Diarrhea
  • Infusion-related reactions
  • Brain edema
  • Microhemorrhages

Frequently Asked Questions about Kisunla (Donanemab)

What is Kisunla (Donanemab) used for?

Kisunla is used to treat early symptomatic Alzheimer's disease, including mild cognitive impairment and mild dementia due to Alzheimer's.

How does Kisunla work?

Kisunla is a monoclonal antibody that targets and helps remove amyloid beta plaques from the brain, which are associated with Alzheimer's disease progression.

What are the most common side effects of Kisunla?

Common side effects include headache, infusion-related reactions (chills, fever, nausea), dizziness, and mild rash.

How is Kisunla administered?

Kisunla is given as an intravenous infusion by a healthcare professional, typically once every four weeks.

Can Kisunla cure Alzheimer's disease?

No, Kisunla does not cure Alzheimer's disease. It may help slow the progression of symptoms in early stages.

Is Kisunla safe for children?

Kisunla is not approved for use in children or adolescents under 18 years of age.

What should I do if I miss a dose?

Contact your healthcare provider to reschedule the missed infusion. Do not attempt to self-administer or double up on doses.

Educational information only. Always consult a qualified healthcare professional before starting, stopping, or changing any medication.